{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T19:18:05Z","timestamp":1772738285409,"version":"3.50.1"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K08953"],"award-info":[{"award-number":["20K08953"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20J00393"],"award-info":[{"award-number":["20J00393"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K06641"],"award-info":[{"award-number":["21K06641"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>\n                    Anaplastic thyroid cancer (ATC) is a rare but highly aggressive malignancy with a dismal prognosis. Although recent advances in targeted therapies have modestly improved survival, the molecular mechanisms driving ATC progression remain incompletely elucidated. Epithelial cell adhesion molecule (EpCAM), a multifunctional cell-surface protein, is implicated in proliferation, migration, and stemness in various cancers. However, its role in thyroid cancer progression remains unclear. In this study, we investigated the function of EpCAM in thyroid cancer cell lines of varying differentiation status. EpCAM expression was significantly elevated in ATC cell lines compared with differentiated thyroid cancer (DTC) lines. EpCAM knockdown by siRNA suppressed proliferation, adhesion, motility, and invasion in ATC cells, but had minimal effects on DTC cells. Morphological analyses revealed that EpCAM silencing induced differentiation features, including follicle-like structure formation and increased expression of thyroid differentiation markers such as thyroglobulin and PAX8 in ATC cells. Furthermore, EpCAM inhibition decreased mesenchymal marker expression, reduced filopodia formation, and suppressed extravasation of cancer cells into the lung in an\n                    <jats:italic>in vivo<\/jats:italic>\n                    mouse model. Mechanistically, EpCAM knockdown attenuated epithelial\u2013mesenchymal transition (EMT)-related pathways but did not affect major proliferation signaling cascades in ATC cells. These findings suggest that EpCAM promotes dedifferentiation and metastatic potential in ATC through EMT modulation. Our results provide new insights into the role of EpCAM in thyroid cancer biology and highlight its potential as a therapeutic target in ATC. Further studies are warranted to elucidate the mechanisms linking EpCAM to anaplastic transformation and to explore the therapeutic efficacy of EpCAM-targeting strategies in aggressive thyroid cancers.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0344276","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T18:34:31Z","timestamp":1772735671000},"page":"e0344276","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["EpCAM silencing suppresses aggressive phenotypes and induces partial redifferentiation in anaplastic thyroid cancer cells"],"prefix":"10.1371","volume":"21","author":[{"given":"Teruo","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6430-0307","authenticated-orcid":true,"given":"Ken-ichi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"issue":"2","key":"pone.0344276.ref001","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/hed.21721","article-title":"Multimodality therapeutic outcomes in anaplastic thyroid carcinoma: improved survival in subgroups of patients with localized primary tumors","volume":"34","author":"K-I Ito","year":"2012","journal-title":"Head Neck"},{"issue":"9","key":"pone.0344276.ref002","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1001\/jamaoncol.2020.3362","article-title":"Evaluation of Overall Survival in Patients With Anaplastic Thyroid Carcinoma, 2000-2019","volume":"6","author":"A Maniakas","year":"2020","journal-title":"JAMA Oncol"},{"issue":"12","key":"pone.0344276.ref003","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1002\/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1","article-title":"A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995","volume":"83","author":"SA Hundahl","year":"1998","journal-title":"Cancer"},{"issue":"3","key":"pone.0344276.ref004","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1053\/ejso.2000.1098","article-title":"Effect of primary treatment on survival in anaplastic thyroid carcinoma","volume":"27","author":"N Besic","year":"2001","journal-title":"Eur J Surg Oncol"},{"key":"pone.0344276.ref005","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fendo.2020.00102","article-title":"Update on Fundamental Mechanisms of Thyroid Cancer","volume":"11","author":"A Prete","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"pone.0344276.ref006","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1093\/annonc\/mdy123","article-title":"Early evolutionary divergence between papillary and anaplastic thyroid cancers","volume":"29","author":"J Capdevila","year":"2018","journal-title":"Ann Oncol"},{"issue":"11","key":"pone.0344276.ref007","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1056\/NEJMra1501993","article-title":"Biologic and Clinical Perspectives on Thyroid Cancer","volume":"375","author":"JA Fagin","year":"2016","journal-title":"N Engl J Med"},{"issue":"2","key":"pone.0344276.ref008","doi-asserted-by":"crossref","first-page":"188262","DOI":"10.1016\/j.bbcan.2018.12.003","article-title":"Molecular aberrations and signaling cascades implicated in the pathogenesis of anaplastic thyroid cancer","volume":"1872","author":"S Saini","year":"2019","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"2","key":"pone.0344276.ref009","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2353\/ajpath.2007.070152","article-title":"Epithelial cell adhesion molecule: more than a carcinoma marker and adhesion molecule","volume":"171","author":"M Trzpis","year":"2007","journal-title":"Am J Pathol"},{"issue":"4","key":"pone.0344276.ref010","first-page":"1771","article-title":"Functions of EpCAM in physiological processes and diseases (Review)","volume":"42","author":"L Huang","year":"2018","journal-title":"Int J Mol Med"},{"issue":"4","key":"pone.0344276.ref011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094487","article-title":"Coexpression of EpCAM, CD44 variant isoforms and claudin-7 in anaplastic thyroid carcinoma","volume":"9","author":"T Okada","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"pone.0344276.ref012","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/sj.bjc.6602924","article-title":"Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers","volume":"94","author":"P Went","year":"2006","journal-title":"Br J Cancer"},{"issue":"3","key":"pone.0344276.ref013","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/sj.bjc.6603494","article-title":"EpCAM (CD326) finding its role in cancer","volume":"96","author":"PA Baeuerle","year":"2007","journal-title":"Br J Cancer"},{"issue":"6","key":"pone.0344276.ref014","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/his.12870","article-title":"Expression of epithelial cell adhesion molecule (EpCAM) in oral squamous cell carcinoma","volume":"68","author":"S Sen","year":"2016","journal-title":"Histopathology"},{"issue":"4","key":"pone.0344276.ref015","article-title":"Relationship between epithelial cell adhesion molecule (EpCAM) overexpression and gastric cancer patients: A systematic review and meta-analysis","volume":"12","author":"M Dai","year":"2017","journal-title":"PLoS One"},{"issue":"7","key":"pone.0344276.ref016","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.21873\/anticanres.12700","article-title":"EpCAM as a Predictive Marker of Tumor Recurrence and Survival in Patients Who Underwent Surgical Resection for Hepatocellular Carcinoma","volume":"38","author":"C-K Noh","year":"2018","journal-title":"Anticancer Res"},{"issue":"1","key":"pone.0344276.ref017","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1186\/s12885-020-07580-z","article-title":"Hepatocellular carcinoma: Intratumoral EpCAM-positive cancer stem cell heterogeneity identifies high-risk tumor subtype","volume":"20","author":"J Krause","year":"2020","journal-title":"BMC Cancer"},{"issue":"11","key":"pone.0344276.ref018","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1210\/jc.2008-1102","article-title":"Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification","volume":"93","author":"RE Schweppe","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"pone.0344276.ref019","first-page":"806","article-title":"Transforming growth factor-beta 1 is a negative regulator for differentiated thyroid cancer: studies of growth, migration, invasion, and adhesion of cultured follicular and papillary thyroid cancer cell lines","volume":"79","author":"T H\u00f6lting","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"pone.0344276.ref020","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/j.1349-7006.2002.tb01245.x","article-title":"Peroxisome proliferator-activated receptor gamma activation induces cell cycle arrest via the p53-independent pathway in human anaplastic thyroid cancer cells","volume":"93","author":"SH Chung","year":"2002","journal-title":"Jpn J Cancer Res"},{"issue":"3","key":"pone.0344276.ref021","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1007\/s00268-013-2409-7","article-title":"Establishment, characterization and comparison of seven authentic anaplastic thyroid cancer cell lines retaining clinical features of the original tumors","volume":"38","author":"N Onoda","year":"2014","journal-title":"World J Surg"},{"issue":"1","key":"pone.0344276.ref022","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10549-011-1731-8","article-title":"Alteration of Y-box binding protein-1 expression modifies the response to endocrine therapy in estrogen receptor-positive breast cancer","volume":"133","author":"T Ito","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"pone.0344276.ref023","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1111\/cas.15465","article-title":"Epidermal growth factor receptor activation confers resistance to lenvatinib in thyroid cancer cells","volume":"113","author":"K Ohno","year":"2022","journal-title":"Cancer Sci"},{"key":"pone.0344276.ref024","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/1471-2407-12-178","article-title":"Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition","volume":"12","author":"TM Gorges","year":"2012","journal-title":"BMC Cancer"},{"issue":"47","key":"pone.0344276.ref025","doi-asserted-by":"crossref","first-page":"82754","DOI":"10.18632\/oncotarget.19787","article-title":"PATZ1 knockdown enhances malignant phenotype in thyroid epithelial follicular cells and thyroid cancer cells","volume":"8","author":"A Iesato","year":"2017","journal-title":"Oncotarget"},{"key":"pone.0344276.ref026","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/1471-2407-10-331","article-title":"EpCAM nuclear localization identifies aggressive thyroid cancer and is a marker for poor prognosis","volume":"10","author":"R Ralhan","year":"2010","journal-title":"BMC Cancer"},{"issue":"2","key":"pone.0344276.ref027","first-page":"429","article-title":"EpCAM (MOC-31) - immunohistochemical profile and clinico-pathological correlations in different histological variants of papillary thyroid carcinoma","volume":"60","author":"EC Andriescu","year":"2019","journal-title":"Rom J Morphol Embryol"},{"issue":"1","key":"pone.0344276.ref028","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1186\/s12885-018-5010-5","article-title":"Epithelial cell adhesion molecule (EpCAM) is involved in prostate cancer chemotherapy\/radiotherapy response in vivo","volume":"18","author":"J Ni","year":"2018","journal-title":"BMC Cancer"},{"key":"pone.0344276.ref029","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.canlet.2018.06.040","article-title":"Extracellular domain of EpCAM enhances tumor progression through EGFR signaling in colon cancer cells","volume":"433","author":"K-H Liang","year":"2018","journal-title":"Cancer Lett"},{"issue":"22","key":"pone.0344276.ref030","doi-asserted-by":"crossref","first-page":"5035","DOI":"10.1158\/0008-5472.CAN-20-1264","article-title":"EpCAM Signaling Promotes Tumor Progression and Protein Stability of PD-L1 through the EGFR Pathway","volume":"80","author":"H-N Chen","year":"2020","journal-title":"Cancer Res"},{"issue":"5","key":"pone.0344276.ref031","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.amjsurg.2006.02.005","article-title":"Derangement of the E-cadherin\/catenin complex is involved in transformation of differentiated to anaplastic thyroid carcinoma","volume":"191","author":"SM Wiseman","year":"2006","journal-title":"Am J Surg"},{"issue":"1","key":"pone.0344276.ref032","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/modpathol.2012.137","article-title":"Expression of epithelial-mesenchymal transition regulators SNAI2 and TWIST1 in thyroid carcinomas","volume":"26","author":"D Buehler","year":"2013","journal-title":"Mod Pathol"},{"issue":"2","key":"pone.0344276.ref033","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3390\/ijms25021121","article-title":"Evaluation of the Therapeutic Effects of Harmine on Anaplastic Thyroid Cancer Cells","volume":"25","author":"E Baldini","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"2","key":"pone.0344276.ref034","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3390\/biom10020255","article-title":"Revisiting the Roles of Pro-Metastatic EpCAM in Cancer","volume":"10","author":"MA Mohtar","year":"2020","journal-title":"Biomolecules"},{"issue":"17","key":"pone.0344276.ref035","doi-asserted-by":"crossref","first-page":"24677","DOI":"10.18632\/oncotarget.8250","article-title":"Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer","volume":"7","author":"K-A Hyun","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"pone.0344276.ref036","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/jnci\/djn419","article-title":"Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells","volume":"101","author":"AM Sieuwerts","year":"2009","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"pone.0344276.ref037","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1200\/JCO.2012.44.2905","article-title":"Circulating tumor cells as prognostic markers in neuroendocrine tumors","volume":"31","author":"MS Khan","year":"2013","journal-title":"J Clin Oncol"},{"issue":"11","key":"pone.0344276.ref038","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1089\/thy.2017.0639","article-title":"Circulating Epithelial Cell Characterization and Correlation with Remission and Survival in Patients with Thyroid Cancer","volume":"28","author":"J-D Lin","year":"2018","journal-title":"Thyroid"},{"issue":"1","key":"pone.0344276.ref039","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12935-024-03378-2","article-title":"Characterization of EpCAM in thyroid cancer biology by three-dimensional spheroids in vitro model","volume":"24","author":"V Ghiandai","year":"2024","journal-title":"Cancer Cell Int"},{"issue":"9","key":"pone.0344276.ref040","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1093\/annonc\/mdr625","article-title":"Phase IB study of the EpCAM antibody adecatumumab combined with docetaxel in patients with EpCAM-positive relapsed or refractory advanced-stage breast cancer","volume":"23","author":"M Schmidt","year":"2012","journal-title":"Ann Oncol"},{"issue":"1","key":"pone.0344276.ref041","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1158\/0008-5472.CAN-11-2235","article-title":"Immunomonitoring results of a phase II\/III study of malignant ascites patients treated with the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3)","volume":"72","author":"M J\u00e4ger","year":"2012","journal-title":"Cancer Res"},{"issue":"8","key":"pone.0344276.ref042","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1093\/annonc\/mds178","article-title":"Deterioration in quality of life (QoL) in patients with malignant ascites: results from a phase II\/III study comparing paracentesis plus catumaxomab with paracentesis alone","volume":"23","author":"P Wimberger","year":"2012","journal-title":"Ann Oncol"},{"issue":"5","key":"pone.0344276.ref043","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/j.juro.2012.07.020","article-title":"A phase II study of oportuzumab monatox: an immunotoxin therapy for patients with noninvasive urothelial carcinoma in situ previously treated with bacillus Calmette-Gu\u00e9rin","volume":"188","author":"M Kowalski","year":"2012","journal-title":"J Urol"},{"issue":"6","key":"pone.0344276.ref044","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.3892\/or.2020.7808","article-title":"Anti\u2011EpCAM monoclonal antibody exerts antitumor activity against oral squamous cell carcinomas","volume":"44","author":"MK Kaneko","year":"2020","journal-title":"Oncol Rep"},{"issue":"4","key":"pone.0344276.ref045","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3390\/antib11040074","article-title":"A Defucosylated Anti-EpCAM Monoclonal Antibody (EpMab-37-mG2a-f) Exerts Antitumor Activity in Xenograft Model","volume":"11","author":"T Asano","year":"2022","journal-title":"Antibodies (Basel)"},{"issue":"48","key":"pone.0344276.ref046","article-title":"EpCAM-targeting CAR-T cell immunotherapy is safe and efficacious for epithelial tumors","volume":"9","author":"D Li","year":"2023","journal-title":"Sci Adv"},{"issue":"2","key":"pone.0344276.ref047","doi-asserted-by":"crossref","DOI":"10.1038\/nrc2499-c1","article-title":"On the abundance of EpCAM on cancer stem cells","volume":"9","author":"O Gires","year":"2009","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"pone.0344276.ref048","doi-asserted-by":"crossref","first-page":"8719","DOI":"10.1074\/jbc.M109.077081","article-title":"Epithelial cell adhesion molecule regulation is associated with the maintenance of the undifferentiated phenotype of human embryonic stem cells","volume":"285","author":"T-Y Lu","year":"2010","journal-title":"J Biol Chem"},{"issue":"1","key":"pone.0344276.ref049","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1038\/s41598-018-20131-8","article-title":"Spatiotemporal patterning of EpCAM is important for murine embryonic endo- and mesodermal differentiation","volume":"8","author":"S Sarrach","year":"2018","journal-title":"Sci Rep"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0344276","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T18:34:40Z","timestamp":1772735680000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0344276"}},"subtitle":[],"editor":[{"given":"Tomohito","family":"Higashi","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":49,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0344276","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]}}}